Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Post by RReis09on Oct 09, 2020 1:53pm
117 Views
Post# 31696430

Europe Is Sleeping Giant Investment Bankers Circling Cannabi

Europe Is Sleeping Giant Investment Bankers Circling Cannabi"Jeffries Is Mentioned. IR Says Beena Had Sit Down With Jeffries. Do The DD And Get Jacked!! " Investors who are eager for the cannabis industry in Europe to emulate the boom in pot-stock listings in Canada may not have much longer to wait, judging by the activities of investment bankers. Canaccord Genuity Inc., the biggest underwriter of stock offerings for weed-related companies, has appointed a head of European cannabis investment banking. French bank Bryan Garnier & Co. in the past year started covering the Canadian sector via a Paris-based analyst. Jefferies Financial Group Inc. recently initiated coverage on a slew of North American pot stocks through a London-based analyst. Embedded Image The firms are laying the groundwork for an expected increase in stock sales and mergers and acquisitions as companies seek to capitalize on Europes growing acceptance of cannabis, particularly for medical uses. There has been significant interest from medical cannabis companies for stock-market listings in Europe, said Tristan Gervais, the London-based Canaccord banker whos spearheading the firms push in the region. A lot of companies from all over the world are looking to raise capital in London, Gervais said. His sense of the market, and going by the experience so far, is that there is a huge appetite from a wide range of investors. Toronto-based Canaccord appointed Gervais as head of European cannabis investment banking in September. That sense is borne out by others. Nick Davis, chief executive of London-based law firm Memery Crystal LLP, said advising firms in the CBD and medical cannabis sectors on raising money is his full-time job at the moment. He said there are enough meetings each week that its taking up the majority of my time.
<< Previous
Bullboard Posts
Next >>